학술논문

Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
Case Reports
Document Type
Academic Journal
Source
Neurosciences. July 2019, Vol. 24 Issue 3, p240, 5 p.
Subject
Development and progression
Health aspects
Lamotrigine -- Health aspects
Schizophrenia -- Development and progression
Status epilepticus -- Development and progression
Antiphospholipid syndrome -- Development and progression
Drug resistance -- Development and progression
Seizures (Medicine) -- Development and progression
Levetiracetam -- Health aspects
Escitalopram -- Health aspects
Language
English
ISSN
1319-6138
Abstract
New-onset refractory status epilepticus (NORSE) is a syndrome of new-onset drug-resistant status epilepticus that often has a catastrophic outcome. Epilepsy is usually associated with psychiatric disorders of different manifestations of [...]
[phrase omitted] New-onset refractory status epilepticus (NORSE) is a drug-resistant status epilepticus that often has a catastrophic outcome. Our patient was diagnosed with NORSE and had an EEG reading that showed status epilepticus persisting for 8 months in general anesthesia. After autoimmune workup showed positive antiphospholipid antibodies, his seizure was controlled, and he was discharged with good condition apart from moderate cognitive impairment. However, he later developed schizophrenia. Although psychiatric disorders have been associated with antiphospholipid syndrome, to the best of our knowledge, it has not been reported to be associated with status epilepticus. We recommend vigilance of psychological complications of refractory status epilepticus' patients for early psychiatric referral, diagnosis, and treatment.